君实生物-U
(688180)
| 流通市值：237.74亿 | | | 总市值：318.48亿 |
| 流通股本：7.66亿 | | | 总股本：10.27亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 2,513,412,108.77 | 1,696,210,935.65 | 726,287,839.6 | 2,498,420,333.97 |
| 营业总成本 | 2,655,871,643.27 | 1,788,098,231.24 | 861,878,028.11 | 3,444,363,178.98 |
| 其他经营收益 | | | | |
| 营业利润 | -231,850,214.74 | -19,012,392.22 | -28,587,860.48 | -999,463,383.92 |
| 利润总额 | -248,291,544.86 | -33,380,161.74 | -37,842,584.71 | -1,023,274,342.07 |
| 净利润 | -220,974,618.89 | -40,823,699.21 | -43,425,421.84 | -1,009,393,410.45 |
| 每股收益 | | | | |
| 其他综合收益 | -164,383.87 | 1,991,646.97 | 5,922,552.06 | -6,750,254.67 |
| 综合收益总额 | -221,139,002.76 | -38,832,052.24 | -37,502,869.78 | -1,016,143,665.12 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 5,681,296,674.78 | 5,205,245,445.33 | 5,874,389,312.73 | 4,457,703,511.07 |
| 非流动资产: | | | | |
| 非流动资产合计 | 9,242,140,639.46 | 8,996,318,247.02 | 8,277,609,988.83 | 7,924,623,384.29 |
| 资产总计 | 14,923,437,314.24 | 14,201,563,692.35 | 14,151,999,301.56 | 12,382,326,895.36 |
| 流动负债: | | | | |
| 流动负债合计 | 2,767,750,980.97 | 2,891,153,672.8 | 2,746,265,120.57 | 2,778,278,033.83 |
| 非流动负债: | | | | |
| 非流动负债合计 | 6,123,740,361.12 | 5,158,946,342.74 | 5,315,626,038.83 | 3,547,454,580.76 |
| 负债合计 | 8,891,491,342.09 | 8,050,100,015.54 | 8,061,891,159.4 | 6,325,732,614.59 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,830,570,102.31 | 5,943,737,286.52 | 5,896,037,652.78 | 6,030,434,432.07 |
| 股东权益合计 | 6,031,945,972.15 | 6,151,463,676.81 | 6,090,108,142.16 | 6,056,594,280.77 |
| 负债和股东权益合计 | 14,923,437,314.24 | 14,201,563,692.35 | 14,151,999,301.56 | 12,382,326,895.36 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,688,722,575.92 | 1,647,575,578.25 | 841,165,588.93 | 2,841,283,482.04 |
| 经营活动现金流出小计 | 2,523,177,981.34 | 1,716,137,799.12 | 783,316,353.94 | 3,360,851,214.36 |
| 经营活动产生的现金流量净额 | 165,544,594.58 | -68,562,220.87 | 57,849,234.99 | -519,567,732.32 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,522,486,654.82 | 2,086,881,874.83 | 660,942,551.93 | 2,325,262,549.2 |
| 投资活动现金流出小计 | 7,250,044,896.97 | 3,525,247,294.15 | 1,202,307,578.74 | 3,905,973,432.42 |
| 投资活动产生的现金流量净额 | -1,727,558,242.15 | -1,438,365,419.32 | -541,365,026.81 | -1,580,710,883.22 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 3,677,681,568.49 | 2,544,089,533.49 | 2,421,047,188.74 | 4,764,723,517.2 |
| 筹资活动现金流出小计 | 1,215,482,334.8 | 899,676,067.44 | 628,698,526.33 | 2,535,417,774.79 |
| 筹资活动产生的现金流量净额 | 2,462,199,233.69 | 1,644,413,466.05 | 1,792,348,662.41 | 2,229,305,742.41 |
| 汇率变动对现金及现金等价物的影响 | -29,474,316.51 | -25,542,687.74 | -12,144,143 | -21,706,525.95 |
| 现金及现金等价物净增加额 | 870,711,269.61 | 111,943,138.12 | 1,296,688,727.59 | 107,320,600.92 |
| 期末现金及现金等价物余额 | 3,464,710,979.35 | 2,705,942,847.86 | 3,890,688,437.33 | 2,593,999,709.74 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 111,943,138.12 | - | 107,320,600.92 |
最新报告期：2026-11-02| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华安证券 | 谭国超 | -0.31 | 0.11 | 0.52 | 2026-11-02 |
| 兴业证券 | 孙媛媛 | -0.25 | 0.07 | 0.48 | 2026-10-07 |
| 天风证券 | 杨松,曹文清 | -0.48 | 0.06 | 0.47 | 2026-09-27 |
| 中邮证券 | 盛丽华 | -0.37 | 0.11 | 0.54 | 2026-09-10 |
| 方正证券 | 许睿 | -0.40 | 0.05 | 0.41 | 2026-08-28 |